Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

MLA

Matteo Santoni, et al. Inflammatory Indices and Clinical Factors in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab: The Development of a Novel Prognostic Score (Meet-URO 15 Study). Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....937608e08d83753dc05d22f57d15ccae&authtype=sso&custid=ns315887.

APA

Matteo Santoni, Sara Elena Rebuzzi, Francesca Vignani, Silvia Chiellino, Sebastiano Buti, Alessio Cortellini, Paolo Andrea Zucali, Hector Soto Parra, Franco Morelli, Cristina Masini, Melissa Bersanelli, Emanuele Naglieri, Giandomenico Roviello, Laura Tomasello, Franco Nolè, Paolo Pedrazzoli, Veronica Prati, Marco Messina, Alessio Signori, … Stefano Panni. (2021). Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).

Chicago

Matteo Santoni, Sara Elena Rebuzzi, Francesca Vignani, Silvia Chiellino, Sebastiano Buti, Alessio Cortellini, Paolo Andrea Zucali, et al. 2021. “Inflammatory Indices and Clinical Factors in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab: The Development of a Novel Prognostic Score (Meet-URO 15 Study),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....937608e08d83753dc05d22f57d15ccae&authtype=sso&custid=ns315887.